CCO Treatment Updates
Management of Depression and HCV: Novel Data, Best Practices, and Case Challenges
Clinical Data and Best Practices for Managing Depression in HCV-Infected Patients Treated With Peginterferon and Ribavirin
|
Module 1 of 2
|
|
|
|
 Martin Schaefer, MD, highlights management strategies for patients with hepatitis C virus infection and depression, highlighting new studies from the past year Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the risk factors for and incidence of depression during interferon-based treatment for HCV infection
- Discuss management strategies for depression in hepatitis C patients, including pretreatment assessment, prevention, and treatment
- Recount the effects of HCV infection and treatment on cognition, sleep patterns, and mood
- Describe the management of psychiatric disorders in hepatitis C patients with concurrent drug addiction
|
Answering the Questions: Depression Related to HCV and Its Treatment (coming soon)
|
Module 2 of 2
|
Slideset Modules
Clinical Data and Best Practices for Managing Depression in HCV-Infected Patients Treated With Peginterferon and Ribavirin
|
|
|
In this slideset module, Martin Schaefer, MD, discusses the relationships among depression, hepatitis C virus, and treatment; management strategies for depression; the effects of hepatitis C virus on cognitive function; and management of psychiatric disorders in the setting of drug addiction. Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the risk factors for and frequency of depression during interferon-based treatment for HCV infection
- Discuss management strategies for depression in hepatitis C patients, including pretreatment assessment, prevention, and treatment
- Recount the effects of HCV infection and treatment on cognition, sleep patterns, and mood
- Describe the management of psychiatric disorders in hepatitis C patients with concurrent drug addiction
|
Clinical Data and Best Practices for Managing Depression in HCV-Infected Patients Treated With Peginterferon and Ribavirin
 |
|
Martin Schaefer, MD, highlights management strategies for patients with hepatitis C virus infection and depression, highlighting new studies from the past year.
Format: Microsoft PowerPoint (.ppt) | File size: 663 KB
|
Depression Related to HCV and Its Treatment (coming soon)
- Michael R. Kraus, MD, PhD
|
|
|
|
Interactive Case Challenges
Management of a Patient With Depressive Symptoms Prior to HCV Therapy (coming soon)
Management of a Patient Without a History of Depression Who Develops Psychiatric Complications During HCV Therapy (coming soon)
Management of Emergent Depression and Suicidal Ideation During HCV Therapy (coming soon)
Expert Viewpoints
Regional Perspectives on the Management of Depression Prior to HCV Therapy
Patrick Marcellin, MD
Regional Perspectives on the Management of a Patient Without a History of Depression Who Develops Psychiatric Complications During HCV Therapy
Martin Schaefer, MD
Regional Perspectives on the Management of Emergent Depression and Suicidal Ideation During HCV Therapy
Michael R. Kraus, MD, PhD
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
Have a question on the management of depression and HCV?
|
|